American Journal of Cardiovascular Drugs 2022 Full Archives

The American Journal of Cardiovascular Drugs is a comprehensive publication dedicated to promoting rational therapy and effective patient management within the field of cardiology. This peer-reviewed journal provides regular independent review articles covering all aspects of the management of cardiovascular disorders, including the place in therapy of newer and established agents and procedures.

The journal features a range of content, including short overviews of contentious or emerging issues, comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease, systematic reviews that collate empirical evidence to answer specific research questions, therapy in practice reviews covering the optimum management of specific conditions, Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine, and original research articles reporting the results of well-designed clinical studies.

One of the unique aspects of the American Journal of Cardiovascular Drugs is the inclusion of additional digital features, such as animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts, and animations. These digital features are designed to increase the visibility, readership, and educational value of the journal’s content.

The journal also offers plain language summaries to assist readers who have some knowledge of but not in-depth expertise in the area to understand important medical advances. This feature makes the American Journal of Cardiovascular Drugs accessible to a wider audience, including healthcare professionals, researchers, and patients.

Each manuscript submitted to the American Journal of Cardiovascular Drugs undergoes rigorous peer review by international experts. Letters to the Editor are also welcomed and considered for publication.

The American Journal of Cardiovascular Drugs is an essential resource for anyone involved in the treatment and management of cardiovascular disease. The journal’s broad range of content, expert peer review, and digital features make it an invaluable source of information and education.

Ordering the American Journal of Cardiovascular Drugs is easy and straightforward. The journal offers a subscription service, which provides access to the latest issues of the journal. Ordering the journal allows healthcare professionals, researchers, and patients to stay up-to-date with the latest developments in the field of cardiology and ensures they have access to the most current and reliable information.

In conclusion, the American Journal of Cardiovascular Drugs is a must-have resource for anyone working in cardiology. Its comprehensive content, expert peer review, and additional digital features make it an invaluable source of information and education. Ordering the journal is a simple process that ensures healthcare professionals, researchers, and patients have access to the most up-to-date and reliable information available.

Product Details

• Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively).
• Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease.
• Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
• Therapy in practice reviews covering optimum management of specific conditions.
• Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine.
• Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies.